Samyang and CJ on strategic alliance for Genexol PM inj.

Published: 2007-01-29 06:58:00

Updated: 2007-01-29 06:58:00

Samyang and CJ signed a strategic marketing alliance agreement at Hilton hotel on Jan. 24 for an exclusive distribution of Genexol PM inj., an anti-cancer drug for the treatment of lung and breast cancer. Genexol PM inj. may be launched to the market some time in coming February.

The similar a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK